These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7001086)

  • 1. A case of renovascular hypertension with high urinary noradrenaline excretion.
    Izumi Y; Honda M; Shiratsuchi T; Hatano M
    Jpn Circ J; 1980 Nov; 44(11):893-8. PubMed ID: 7001086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary excretion of catecholamines and their metabolites in patients with renovascular hypertension.
    Januszewicz W; Wocial B
    Jpn Heart J; 1978 Jul; 19(4):468-78. PubMed ID: 731871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibition of the angiotensin I converting enzyme with SQ-14225 (captopril) in the medical treatment of severe renovascular hypertension].
    Martínez Amenós A; Caralps A; Rama H; Sarrias X; Alsina J
    Rev Clin Esp; 1981 Sep; 162(6):265-8. PubMed ID: 7036249
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulation of renal hemodynamics and glomerular filtration in patients with renovascular hypertension during converting enzyme inhibition with captopril.
    Textor SC; Tarazi RC; Novick AC; Bravo EL; Fouad FM
    Am J Med; 1984 May; 76(5B):29-37. PubMed ID: 6328984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of renovascular hypertension with the nephrotic syndrome.
    Fujioka S; Sasakawa O; Suzuki R; Nogi O; Tsumura K; Komori T; Morii H
    Jpn J Med; 1986 Aug; 25(3):317-20. PubMed ID: 3534395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability of captopril renography in patients under chronic therapy with angiotensin II (AT1) receptor antagonists.
    Picciotto G; Sargiotto A; Petrarulo M; Rabbia C; De Filippi PG; Roccatello D
    J Nucl Med; 2003 Oct; 44(10):1574-81. PubMed ID: 14530469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participation of the renin system in treatment-resistant hypertension as measured by acute blockade of the angiotensin converting enzyme.
    Weber MA; Drayer JI; Priest RT; Chen TC
    Am J Nephrol; 1982; 2(1):6-11. PubMed ID: 6295161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extra-adrenal pheochromocytoma manifesting renovascular hypertension.
    Kohara K; Mikami H; Ogihara T; Hashizume K; Kumahara Y; Kojima Y; Takahara S; Takaha M; Sonoda T; Tokunaga K
    J Clin Hypertens; 1987 Sep; 3(3):303-9. PubMed ID: 3668590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactive hyperreninemia in renovascular hypertension after angiotensin blockage with saralasin or converting enzyme inhibitor.
    Case DB; Laragh JH
    Ann Intern Med; 1979 Aug; 91(2):153-60. PubMed ID: 464461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Water-salt balance, plasma renin activity and catecholamine excretion in renovascular hypertension in the rat.
    de la Riva IJ; Morera S; Kurnjek ML; Basso N; Domínguez Mon M; Taquini AC
    Arch Int Physiol Biochim; 1981 May; 89(2):115-25. PubMed ID: 6167229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A screening test for renovascular hypertension by means of orally active angiotensin I converting enzyme inhibitor, captopril (SQ 14225).
    Imai Y; Abe K; Otsuka Y; Sakurai Y; Yoshinaga K
    Tohoku J Exp Med; 1980 Jul; 131(3):311-2. PubMed ID: 6998048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Captopril renography in the diagnosis of renovascular hypertension].
    Jensen JJ; Møller ML; Lund JO; Trap-Jensen J
    Ugeskr Laeger; 1991 Jun; 153(23):1648-51. PubMed ID: 2058027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive effects of captopril and saralasin in essential and renal hypertension.
    Konrads A; Meurer KA; Hummerich W; Wambach G; Kindler J; Feltkamp H; Helber A
    Am J Cardiol; 1982 Apr; 49(6):1558-60. PubMed ID: 7041597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective analysis of strategies for diagnosing renovascular hypertension.
    Svetkey LP; Himmelstein SI; Dunnick NR; Wilkinson RH; Bollinger RR; McCann RL; Beytas EM; Klotman PE
    Hypertension; 1989 Sep; 14(3):247-57. PubMed ID: 2670763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of angiotensin I converting enzyme inhibitor (SQ 14,225) on the responses of blood pressure and steroid hormone to angiotensin II and ACTH infusion in hypertensive subjects.
    Ueda Y; Honda M; Hatano M
    Jpn Circ J; 1982 Mar; 46(3):267-73. PubMed ID: 6278173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonidine lowers blood pressure independently of renin suppression in patients with unilateral renal artery stenosis.
    Mathias CJ; Wilkinson A; Lewis PS; Peart WS; Sever PS; Snell ME
    Chest; 1983 Feb; 83(2 Suppl):357-9. PubMed ID: 6337026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Captopril in the treatment of refractory high-renin hypertension.
    Cutfield R; Sharpe DN; Clarke ED
    N Z Med J; 1980 Jun; 91(661):424-6. PubMed ID: 6104314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal handling of angiotensins I and II in patients with renovascular hypertension.
    Hesse B; Rasmussen S; Giese J; Damkjaer Nielsen M; Høilund-Carlsen PF
    J Hypertens; 1986 Feb; 4(1):113-9. PubMed ID: 3514744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between plasma renin activity and urinary catecholamines in various types of hypertension.
    Horký K; Kopecká J; Greogorová I; Dvoráková J
    Endokrinologie; 1976 Jul; 67(3):331-42. PubMed ID: 976208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Renovascular hypertension. Radionuclide renography for detection and prediction of clinical response to revascularization].
    Muñoz A; Massardo T; González P
    Rev Med Chil; 1996 Sep; 124(9):1116-26. PubMed ID: 9197027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.